"believes," "anticipates," "plans," "estimates," "projects,"
"assumes," "guides," "targets," "forecasts," and "seeks" or the negative of
such terms or other variations on such terms or comparable terminology.
These statements are not guarantees of future performance and involve
risks, uncertainties and assumptions that could cause actual outcomes and
results to differ materially. These risks and uncertainties include, but
are not limited to, our ability to successfully integrate acquired
businesses, the outcome of the Department of Justice investigations
announced in March 2005 and June 2006, price and product competition, rapid
technological development, demographic changes, dependence on new product
development, the mix of our products and services, supply and prices of raw
materials and products, customer demand for our products and services,
control of costs and expenses, our ability to form and implement alliances,
international growth, governmental laws and regulations affecting our U.S.
and international businesses, including tax obligations and risks, product
liability and intellectual property litigation losses, reimbursement levels
from third-party payors, general industry and market conditions and growth
rates and general domestic and international economic conditions including
interest rate and currency exchange rate fluctuations. For a further list
and description of such risks and uncertainties, see our periodic reports
filed with the U.S. Securities and Exchange Commission. We disclaim any
intention or obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise, except
as may be set forth in our periodic reports. Readers of this document are
cautioned not to place undue reliance on these forward-looking statements,
since, while we believe the assumptions on which the forward-looking
statements are based are reasonable, there can be no assurance that these
forward-looking statements
'/>"/>SOURCE Tutogen Medical, Inc. Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related biology technology :1.
Speaker announces business members of IT Task Force2.
Doyle announces technology tax credits for Berbee3.
Doyle announces new energy, global warming policies4.
Doyle, WARF announce partnership to lure stem cell companies5.
Doyle announces $80M renewable energy strategy6.
GE announces first installation of Discovery VCT7.
UWM announces winners of RGI awards8.
Third Wave announces two senior management appointments9.
Mirus announces new method for making antibodies10.
Merge announces sofware updates, upcoming acquisition11.
Small Tree announces ethernet solution for Apple Xserv G5